Endeavor

Volunteers Provide Comfort and Companionship in Patients’ Final Days

For patients whose families and friends cannot be with them, Moffitt volunteers fill a special role

New Drug Shows Promise for Chronic Myeloid Leukemia Patients

Asciminib outperforms standard therapies in phase 3 trial

Landmark Lung Cancer Studies Set to Alter Standard of Care

New data reveals significant survival benefits for patients with stage 3 unresectable non-small cell and limited-stage small cell lung cancers

Targeted Therapy Shows Promise as Earlier Treatment for Metastatic Breast Cancer

Enhertu proves effective in HER2-low metastatic breast cancer with disease progression after endocrine therapy

New Study Reveals HPV Vaccine Benefits Men, Too

Findings underscore vaccine's effectiveness in preventing not only cervical cancer but also head and neck cancers in males

Percutaneous Hepatic Perfusion Should Be Done First and Early for Metastatic Uveal Melanoma Patients

The pivotal phase III FOCUS study shows percutaneous hepatic perfusion (PHP) is best option

Moffitt Scientists Present Groundbreaking Clinical Research at ASCO

Presentations include advances in targeted therapies, immunotherapy and patient care

New Combination Therapy Brings Hope to Bladder Cancer Patients

Innovative treatment shows high success rates in overcoming standard therapy resistance

Using First-of-its-Kind Vaccine to Treat Leptomeningeal Disease

Dendritic cell vaccine may prolong survival well past dismal prognosis